AcuCort AB announced that the company has finalized the process to recruit a permanent CEO and that Carl Johan Fredin will assume the CEO position in late May. The current interim CEO Ann Gidner remains in her role and will ensure a good handover. Carl Johan has almost 30 years’ experience from leading commercial positions as well as the CEO role in the life science sector and especially in the pharmaceutical industry. Currently, he is Country Director, Public Care, at Doro AB. His career besides Doro AB includes GlaxoSmithKline AB, a number of positions within Janssen-Cilag AB as well as Global Health Partner AB, Aleris AB and Mundipharma Sweden AB. In his various roles, Carl Johan has been responsible for and worked with; start-up of new business units, establishment of international distribution channels, launch of new products in international markets, pricing and reimbursement negotiations with authorities, improvement of sales methods and launch of digital marketing tools.